Evidence map›Paper›PMID 36421309›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Octenidine's Efficacy: A Matter of Interpretation or the Influence of Experimental Setups?

Djenana Vejzovic, Azra Iftic, Ayse Ön, Enrico F Semeraro, Nermina Malanovic

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Bactericidal Activity toAntibiotics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Djenana VejzovicInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Azra IfticInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.ORCID 0000-0002-0797-9130
Ayse ÖnInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.
Enrico F SemeraroInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.ORCID 0000-0002-6096-1108
Nermina MalanovicInstitute of Molecular Biosciences, University of Graz, 8010 Graz, Austria.ORCID 0000-0002-2903-9369
University of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With its broad antimicrobial spectrum and non-specific mode of action via membrane disruption, any resistance to octenidine (OCT) seems unlikely and has not been observed in clinical settings so far. In this study, we aimed to investigate the efficacy of OCT against

Indexed as

adaptionbinding to bacteriaBioscreencell densityE. coliinoculum effectlipid mutantsmechanism of actionMICmultidrug resistanceoctenidineQUANTOMTMreduced susceptibilityresistancetolerance

Identifiers

PMID36421309
PMCPMC9686575
OpenAlexW4309787142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.